For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Beam Therapeutics Inc.

USPTO Granted Patents = 12

CIPO Patents = 2

Trademarks = 4

Forward Citations = 28

Loading Chart...

Loading Chart...

27 inventors (with patents filed for the assignee):

Michael S Packer (7 out of 11 patents)

Nicole Marie Gaudelli (7 out of 11 patents)

Ian Slaymaker (5 out of 21 patents)

4. Seung-Joo Lee (5 out of 8 patents)

5. David A Born (5 out of 5 patents)

6. Bernd Zetsche (5 out of 27 patents)

7. Yi Yu (5 out of 177 patents)

8. Jason Michael Gehrke (3 out of 7 patents)

9. Gregory Lawrence Hamilton (3 out of 5 patents)

10. Cory Dane Sago (3 out of 3 patents)

11. Neeraj Narendra Patwardhan (2 out of 2 patents)

12. John Evans (2 out of 2 patents)

13. David R Liu (1 out of 150 patents)

14. J Keith Joung (1 out of 75 patents)

15. Natalie Petrossian (1 out of 1 patent)

12 patents: Sort by Forward Citations

1. 12454694 - Compositions and methods for improving base editing (2025-10-28),

2. 12296053 - Nanomaterials comprising triols (2025-05-13),

3. 12268753 - Nanomaterials comprising a biodegradable feature (2025-04-08),

4. 12133884 - Methods of substituting pathogenic amino acids using programmable base editor systems (2024-11-05),

5. 12125145 - Systems and methods for implemented mixed reality in laboratory automation (2024-10-22),

6. 12059477 - Nanomaterials (2024-08-13),

7. 12016908 - Compositions and methods for treating hemoglobinopathies (2024-06-25),

8. 11795443 - Uses of adenosine base editors (2023-10-24),

9. 11752202 - Compositions and methods for treating hemoglobinopathies (2023-09-12),

10. 11344609 - Compositions and methods for treating hemoglobinopathies (2022-05-31),

11. 11155803 - Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence (2021-10-26),

12. 11142760 - Compositions and methods for treating hemoglobinopathies (2021-10-12),

Beam Therapeutics is a biotechnology company that is developing precision genetic medicines for patients with serious diseases. Using their proprietary CRISPR base editing technology, Beam is working to create a new class of therapies that can address a wide range of genetic mutations. The company is focused on advancing innovative treatments for diseases such as sickle cell disease, beta-thalassemia, and other genetic disorders.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

12 Patents

#177 in Cambridge, MA

#1,500 in Massachusetts

#24,779 in US

#46,665 in the World

Cambridge, MA, United States of America

Beam Therapeutics Inc.

Forward Citations = 28

27 inventors:

Michael S Packer (7 out of 11 patents)

Nicole Marie Gaudelli (7 out of 11 patents)

Ian Slaymaker (5 out of 21 patents)

4. Seung-Joo Lee (5 out of 8 patents)

5. David A Born (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…